SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014738
Filing Date
2022-05-23
Accepted
2022-05-23 14:15:32
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 664412
2 ex31-1.htm EX-31.1 17042
3 ex31-2.htm EX-31.2 17013
4 ex32-1.htm EX-32.1 7029
5 ex32-2.htm EX-32.2 7154
6 form10-q_001.jpg GRAPHIC 3044
  Complete submission text file 0001493152-22-014738.txt   3178062

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE orgs-20220331.xsd EX-101.SCH 30137
8 XBRL CALCULATION FILE orgs-20220331_cal.xml EX-101.CAL 52497
9 XBRL DEFINITION FILE orgs-20220331_def.xml EX-101.DEF 86638
10 XBRL LABEL FILE orgs-20220331_lab.xml EX-101.LAB 254892
11 XBRL PRESENTATION FILE orgs-20220331_pre.xml EX-101.PRE 169408
41 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 331078
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 22950896
SIC: 2834 Pharmaceutical Preparations